Abstract | PURPOSE OF REVIEW: To evaluate the treatment revolution atopic dermatitis, the most common inflammatory skin disease, has been going through in recent years, thanks to breakthroughs in disease understanding, delineating the immune fingerprint of atopic dermatitis. RECENT FINDINGS: SUMMARY:
|
Authors | Yael Renert-Yuval, Emma Guttman-Yassky |
Journal | Current opinion in allergy and clinical immunology
(Curr Opin Allergy Clin Immunol)
Vol. 18
Issue 4
Pg. 356-364
(08 2018)
ISSN: 1473-6322 [Electronic] United States |
PMID | 29870461
(Publication Type: Journal Article, Review)
|
Chemical References |
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
- Cytokines
- Dermatologic Agents
- HRH4 protein, human
- Histamine Antagonists
- Receptors, Histamine H4
- dupilumab
- Janus Kinases
|
Topics |
- Antibodies, Monoclonal
(pharmacology, therapeutic use)
- Antibodies, Monoclonal, Humanized
- Clinical Trials as Topic
- Cytokines
(antagonists & inhibitors, immunology)
- Dermatitis, Atopic
(diagnosis, drug therapy, immunology)
- Dermatologic Agents
(pharmacology, therapeutic use)
- Histamine Antagonists
(pharmacology, therapeutic use)
- Humans
- Janus Kinases
(antagonists & inhibitors, immunology)
- Receptors, Histamine H4
(antagonists & inhibitors, immunology)
- Severity of Illness Index
- Skin
(drug effects, immunology)
- T-Lymphocyte Subsets
(drug effects, immunology)
- Treatment Outcome
|